Hemostats Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Integra LifeSciences Corporation
- Baxter AG
- Medtronic plc
- Stryker Inc.
- BD (Becton, Dickinson, and Company)
- Biom’up Innovative Surgery
- Johnson & Johnson Services, Inc.
- CryoLife, Inc.
- Hemostatis LLC
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of hemostats is evaluated at USD 3.18 Billion.
The global hemostats market size exceeded USD 3 Billion in 2025 and is set to expand at a CAGR of over 6.6%, surpassing USD 5.68 Billion revenue by 2035.
The North America hemostats market will secure around 44.6% share by 2035, driven by early adoption of advanced medical products and rising demand for hemostat solutions.
Key players in the market include Pfizer Inc., Integra LifeSciences Corporation, Baxter, Medtronic, Stryker, BD (Becton, Dickinson and Company), Biom'up Innovative Surgery, Johnson & Johnson Services, Inc., CryoLife, Inc., Hemostatis LLC.
